Listed by the USPTO as STANLEY, JARROD LEE
Tech Center 1600 • Art Units: 1629
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18911325 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | Non-Final OA | Gilead Sciences, Inc. |
| 18917086 | METHOD OF TREATING VIRUS-ASSOCIATED INFECTION USING ACETAMINOPHEN | Non-Final OA | Sanbiozi Medical Science Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyJarrod Lee Stanley examines applications in Art Unit 1629 in Tech Center 1600 (Biotechnology & Pharmaceuticals).